Bjerre, M. T., Strand, S. H., Nørgaard, M., Kristensen, H., Rasmussen, A. K., Mortensen, M. M., . . . Sørensen, K. D. (2019). Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. Int J Mol Sci.
Chicago Style aipamenaBjerre, Marianne T., et al. "Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation Has Potential As a Prognostic Biomarker for Prostate Cancer." Int J Mol Sci 2019.
MLA aipamenaBjerre, Marianne T., et al. "Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation Has Potential As a Prognostic Biomarker for Prostate Cancer." Int J Mol Sci 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.